Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2010 6
2011 1
2012 1
2013 1
2014 2
2015 3
2016 1
2017 3
2018 5
2019 8
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3.
Sun J, Du Y, Zhang X, Wang Z, Lin Y, Song Q, Wang X, Guo J, Li S, Nan J, Yang J. Sun J, et al. Among authors: Nan J. Invest New Drugs. 2019 Oct 14. doi: 10.1007/s10637-019-00853-w. Online ahead of print. Invest New Drugs. 2019. PMID: 31612426
TGF-β2 antagonizes IL-6-promoted cell survival.
Du Y, Sun J, Liu X, Nan J, Qin X, Wang X, Guo J, Zhao C, Yang J. Du Y, et al. Among authors: Nan J. Mol Cell Biochem. 2019 Nov;461(1-2):119-126. doi: 10.1007/s11010-019-03595-8. Epub 2019 Jul 29. Mol Cell Biochem. 2019. PMID: 31359244
34 results
Jump to page
Feedback